Key Insights

Highlights

Treatment Research

1 treatments under study, led by Syndrome Cause Identification

Research Leaders

5 sponsors active, led by University of California, San Francisco

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting2

Clinical Trials (2)

Research Network

Common Treatments

  • Syndrome Cause Identification1

Active Sponsors

  • University of California, San Francisco1
  • Baylor College of Medicine1
  • University of Washington1
  • Aicardi Syndrome Foundation1
  • California Institute of Technology1

Top Investigators

Related Conditions

  • Brain Disorders2

Activity Timeline